PICALM and gastric cancer: PICALM has two subtypes PICALML and PICALMS, PICALML has twenty-two exons that enhance oxaliplatin resistance, whereas PICALMS lacks exon 14 compared to LICALML, resulting in chemosensitivity in GC.